203 related articles for article (PubMed ID: 21239717)
1. Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.
Jiang W; Lederman MM; Harding CV; Sieg SF
J Immunol; 2011 Feb; 186(4):2080-6. PubMed ID: 21239717
[TBL] [Abstract][Full Text] [Related]
2. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
[TBL] [Abstract][Full Text] [Related]
3. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12.
Shirota H; Sano K; Hirasawa N; Terui T; Ohuchi K; Hattori T; Tamura G
J Immunol; 2002 Jul; 169(2):787-94. PubMed ID: 12097381
[TBL] [Abstract][Full Text] [Related]
4. CpG-DNA aided cross-priming by cross-presenting B cells.
Heit A; Huster KM; Schmitz F; Schiemann M; Busch DH; Wagner H
J Immunol; 2004 Feb; 172(3):1501-7. PubMed ID: 14734727
[TBL] [Abstract][Full Text] [Related]
5. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
[TBL] [Abstract][Full Text] [Related]
7. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
[TBL] [Abstract][Full Text] [Related]
8. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
10. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
11. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells.
Schurich A; Berg M; Stabenow D; Böttcher J; Kern M; Schild HJ; Kurts C; Schuette V; Burgdorf S; Diehl L; Limmer A; Knolle PA
J Immunol; 2010 Apr; 184(8):4107-14. PubMed ID: 20212092
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
[TBL] [Abstract][Full Text] [Related]
13. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
[TBL] [Abstract][Full Text] [Related]
14. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
[TBL] [Abstract][Full Text] [Related]
15. The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8
Papagno L; Kuse N; Lissina A; Gostick E; Price DA; Appay V; Nicoli F
Sci Rep; 2020 Jul; 10(1):11620. PubMed ID: 32669577
[TBL] [Abstract][Full Text] [Related]
16. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons.
Sun S; Zhang X; Tough D; Sprent J
Springer Semin Immunopathol; 2000; 22(1-2):77-84. PubMed ID: 10944802
[TBL] [Abstract][Full Text] [Related]
17. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
18. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA.
Kuchtey J; Chefalo PJ; Gray RC; Ramachandra L; Harding CV
J Immunol; 2005 Aug; 175(4):2244-51. PubMed ID: 16081792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
